154 related articles for article (PubMed ID: 19727252)
1. Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.
Weisler RH; Kalali AH; Cutler AJ; Gazda TD; Ginsberg L
Psychiatry (Edgmont); 2008 May; 5(5):49-60. PubMed ID: 19727252
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.
Weisler RH; Kalali AH; Cutler AJ; Gazda TD; Ginsberg L
Psychiatry (Edgmont); 2008 Mar; 5(3):35-48. PubMed ID: 22778707
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
4. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
Ketter TA; Kalali AH; Weisler RH;
J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
[TBL] [Abstract][Full Text] [Related]
5. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
[TBL] [Abstract][Full Text] [Related]
6. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
7. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
[TBL] [Abstract][Full Text] [Related]
8. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
9. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.
Kanba S; Murasaki M; Koyama T; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
BMC Psychiatry; 2019 Jun; 19(1):198. PubMed ID: 31242884
[TBL] [Abstract][Full Text] [Related]
10. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
[TBL] [Abstract][Full Text] [Related]
12. Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.
Murasaki M; Koyama T; Kanba S; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
Psychopharmacology (Berl); 2018 Oct; 235(10):2859-2869. PubMed ID: 30069587
[TBL] [Abstract][Full Text] [Related]
13. Switching from other agents to extended-release carbamazepine in acute mania.
El-Mallakh RS; Ketter TA; Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Keck P; Swann AC; Kalali AH
Psychopharmacol Bull; 2008; 41(1):52-8. PubMed ID: 18362871
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study.
Calabrese JR; Jin N; Johnson B; Such P; Baker RA; Madera J; Hertel P; Ottinger J; Amatniek J; Kawasaki H
Int J Bipolar Disord; 2018 Jun; 6(1):14. PubMed ID: 29886522
[TBL] [Abstract][Full Text] [Related]
16. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
19. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]